2nd Quarter - Report — TODD STRATEGY GROUP for GENENTECH, INC. (2019)

Firm

TODD STRATEGY GROUP

Client

GENENTECH, INC.

Income

$60,000

Expenses

—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare and Medicaid payment issues. Medicare reimbursement for biosimilars. Medicare reimbursement for novel therapies. Prescription drug payment reform. President's American Patients First Blueprint.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD	Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.